JP2016520807A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016520807A5 JP2016520807A5 JP2016502595A JP2016502595A JP2016520807A5 JP 2016520807 A5 JP2016520807 A5 JP 2016520807A5 JP 2016502595 A JP2016502595 A JP 2016502595A JP 2016502595 A JP2016502595 A JP 2016502595A JP 2016520807 A5 JP2016520807 A5 JP 2016520807A5
- Authority
- JP
- Japan
- Prior art keywords
- sample
- fluid
- flow
- cells
- imaging
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000012530 fluid Substances 0.000 claims description 1079
- 238000003384 imaging method Methods 0.000 claims description 611
- 238000000034 method Methods 0.000 claims description 322
- 239000008280 blood Substances 0.000 claims description 265
- 210000004369 blood Anatomy 0.000 claims description 264
- 238000002347 injection Methods 0.000 claims description 102
- 239000007924 injection Substances 0.000 claims description 102
- 239000003795 chemical substances by application Substances 0.000 claims description 79
- 239000007788 liquid Substances 0.000 claims description 76
- 230000003993 interaction Effects 0.000 claims description 38
- 238000004891 communication Methods 0.000 claims description 37
- 230000035899 viability Effects 0.000 claims description 19
- 230000009467 reduction Effects 0.000 claims description 11
- 239000000523 sample Substances 0.000 description 1370
- 210000004027 cell Anatomy 0.000 description 949
- 239000002245 particle Substances 0.000 description 831
- 230000003287 optical effect Effects 0.000 description 216
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 210
- 210000003743 erythrocyte Anatomy 0.000 description 157
- 210000000265 leukocyte Anatomy 0.000 description 129
- 238000006073 displacement reaction Methods 0.000 description 102
- 230000000007 visual effect Effects 0.000 description 99
- 238000001514 detection method Methods 0.000 description 83
- 239000000203 mixture Substances 0.000 description 82
- 210000001772 blood platelet Anatomy 0.000 description 77
- 238000004458 analytical method Methods 0.000 description 75
- 230000007704 transition Effects 0.000 description 69
- 210000000601 blood cell Anatomy 0.000 description 65
- 230000008569 process Effects 0.000 description 56
- 239000002872 contrast media Substances 0.000 description 52
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 48
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 48
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 48
- 239000000306 component Substances 0.000 description 46
- 230000000694 effects Effects 0.000 description 43
- 239000012798 spherical particle Substances 0.000 description 42
- 230000008859 change Effects 0.000 description 38
- 238000009826 distribution Methods 0.000 description 35
- 238000010186 staining Methods 0.000 description 35
- 238000012545 processing Methods 0.000 description 32
- 239000004034 viscosity adjusting agent Substances 0.000 description 30
- 230000007246 mechanism Effects 0.000 description 29
- 238000005549 size reduction Methods 0.000 description 29
- 238000012360 testing method Methods 0.000 description 28
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 27
- 210000003463 organelle Anatomy 0.000 description 27
- 230000006870 function Effects 0.000 description 26
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 24
- 230000002829 reductive effect Effects 0.000 description 24
- 239000003085 diluting agent Substances 0.000 description 23
- 230000003834 intracellular effect Effects 0.000 description 23
- 238000004820 blood count Methods 0.000 description 22
- 238000005286 illumination Methods 0.000 description 22
- 238000003860 storage Methods 0.000 description 21
- 210000005061 intracellular organelle Anatomy 0.000 description 18
- 230000006835 compression Effects 0.000 description 17
- 238000007906 compression Methods 0.000 description 17
- 230000001965 increasing effect Effects 0.000 description 17
- 210000004698 lymphocyte Anatomy 0.000 description 16
- 210000000440 neutrophil Anatomy 0.000 description 16
- 210000001995 reticulocyte Anatomy 0.000 description 16
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 15
- 230000002159 abnormal effect Effects 0.000 description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
- 239000000126 substance Substances 0.000 description 15
- 210000003651 basophil Anatomy 0.000 description 14
- 238000009472 formulation Methods 0.000 description 14
- 210000001616 monocyte Anatomy 0.000 description 14
- 239000008191 permeabilizing agent Substances 0.000 description 14
- 238000010586 diagram Methods 0.000 description 13
- 210000003979 eosinophil Anatomy 0.000 description 13
- 238000010191 image analysis Methods 0.000 description 13
- 238000005259 measurement Methods 0.000 description 13
- 210000003887 myelocyte Anatomy 0.000 description 13
- 230000001052 transient effect Effects 0.000 description 13
- 102000001554 Hemoglobins Human genes 0.000 description 12
- 108010054147 Hemoglobins Proteins 0.000 description 12
- 239000013078 crystal Substances 0.000 description 12
- 230000004044 response Effects 0.000 description 12
- 229920002307 Dextran Polymers 0.000 description 11
- 229960002086 dextran Drugs 0.000 description 11
- 201000010099 disease Diseases 0.000 description 11
- SQHOAFZGYFNDQX-UHFFFAOYSA-N ethyl-[7-(ethylamino)-2,8-dimethylphenothiazin-3-ylidene]azanium;chloride Chemical compound [Cl-].S1C2=CC(=[NH+]CC)C(C)=CC2=NC2=C1C=C(NCC)C(C)=C2 SQHOAFZGYFNDQX-UHFFFAOYSA-N 0.000 description 11
- 238000001802 infusion Methods 0.000 description 11
- 238000000926 separation method Methods 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 238000011282 treatment Methods 0.000 description 11
- 238000004422 calculation algorithm Methods 0.000 description 10
- 230000009028 cell transition Effects 0.000 description 10
- 239000003153 chemical reaction reagent Substances 0.000 description 10
- 238000003745 diagnosis Methods 0.000 description 10
- SEACYXSIPDVVMV-UHFFFAOYSA-L eosin Y Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C([O-])=C(Br)C=C21 SEACYXSIPDVVMV-UHFFFAOYSA-L 0.000 description 10
- 230000033001 locomotion Effects 0.000 description 10
- 210000004940 nucleus Anatomy 0.000 description 10
- 239000002202 Polyethylene glycol Substances 0.000 description 9
- 230000008901 benefit Effects 0.000 description 9
- 239000013060 biological fluid Substances 0.000 description 9
- 238000009534 blood test Methods 0.000 description 9
- 210000000170 cell membrane Anatomy 0.000 description 9
- 230000001413 cellular effect Effects 0.000 description 9
- 150000002314 glycerols Chemical class 0.000 description 9
- 208000015181 infectious disease Diseases 0.000 description 9
- 229920001223 polyethylene glycol Polymers 0.000 description 9
- CIBMHJPPKCXONB-UHFFFAOYSA-N propane-2,2-diol Chemical compound CC(C)(O)O CIBMHJPPKCXONB-UHFFFAOYSA-N 0.000 description 9
- 230000005856 abnormality Effects 0.000 description 8
- 238000013459 approach Methods 0.000 description 8
- 230000005484 gravity Effects 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 238000012552 review Methods 0.000 description 8
- 239000004094 surface-active agent Substances 0.000 description 8
- 229920003169 water-soluble polymer Polymers 0.000 description 8
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 7
- 239000000872 buffer Substances 0.000 description 7
- 210000002421 cell wall Anatomy 0.000 description 7
- 238000012512 characterization method Methods 0.000 description 7
- 239000012634 fragment Substances 0.000 description 7
- 230000015654 memory Effects 0.000 description 7
- 239000011780 sodium chloride Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000004883 computer application Methods 0.000 description 6
- 239000008187 granular material Substances 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 210000004765 promyelocyte Anatomy 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 238000010790 dilution Methods 0.000 description 5
- 239000012895 dilution Substances 0.000 description 5
- 238000001125 extrusion Methods 0.000 description 5
- 238000000684 flow cytometry Methods 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- 230000036961 partial effect Effects 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 230000001120 cytoprotective effect Effects 0.000 description 4
- 239000008367 deionised water Substances 0.000 description 4
- 229910021641 deionized water Inorganic materials 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 238000005534 hematocrit Methods 0.000 description 4
- 230000000977 initiatory effect Effects 0.000 description 4
- 201000004792 malaria Diseases 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 230000008722 morphological abnormality Effects 0.000 description 4
- 238000005457 optimization Methods 0.000 description 4
- 239000003002 pH adjusting agent Substances 0.000 description 4
- 244000045947 parasite Species 0.000 description 4
- 238000011192 particle characterization Methods 0.000 description 4
- 239000013610 patient sample Substances 0.000 description 4
- 230000008823 permeabilization Effects 0.000 description 4
- 239000002953 phosphate buffered saline Substances 0.000 description 4
- 235000021251 pulses Nutrition 0.000 description 4
- 238000005070 sampling Methods 0.000 description 4
- 229930182490 saponin Natural products 0.000 description 4
- 150000007949 saponins Chemical class 0.000 description 4
- 235000017709 saponins Nutrition 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 210000001185 bone marrow Anatomy 0.000 description 3
- 210000002798 bone marrow cell Anatomy 0.000 description 3
- 230000003833 cell viability Effects 0.000 description 3
- 239000002738 chelating agent Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000012937 correction Methods 0.000 description 3
- 230000009089 cytolysis Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000000834 fixative Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000002489 hematologic effect Effects 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 230000000877 morphologic effect Effects 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 3
- 238000010008 shearing Methods 0.000 description 3
- 239000011550 stock solution Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 2
- 206010053567 Coagulopathies Diseases 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 229920002907 Guar gum Polymers 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 208000036142 Viral infection Diseases 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 208000022362 bacterial infectious disease Diseases 0.000 description 2
- 239000012472 biological sample Substances 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 239000006172 buffering agent Substances 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 230000009087 cell motility Effects 0.000 description 2
- 210000003855 cell nucleus Anatomy 0.000 description 2
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 2
- 230000035602 clotting Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 208000031513 cyst Diseases 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 238000002405 diagnostic procedure Methods 0.000 description 2
- 239000012470 diluted sample Substances 0.000 description 2
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- -1 dynamic range Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- 235000019256 formaldehyde Nutrition 0.000 description 2
- 229960004279 formaldehyde Drugs 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 210000003714 granulocyte Anatomy 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 229960002154 guar gum Drugs 0.000 description 2
- 239000000416 hydrocolloid Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000004807 localization Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000005226 mechanical processes and functions Effects 0.000 description 2
- DWCZIOOZPIDHAB-UHFFFAOYSA-L methyl green Chemical compound [Cl-].[Cl-].C1=CC(N(C)C)=CC=C1C(C=1C=CC(=CC=1)[N+](C)(C)C)=C1C=CC(=[N+](C)C)C=C1 DWCZIOOZPIDHAB-UHFFFAOYSA-L 0.000 description 2
- 239000003607 modifier Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 2
- 229960004919 procaine Drugs 0.000 description 2
- 238000003672 processing method Methods 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 239000011435 rock Substances 0.000 description 2
- OARRHUQTFTUEOS-UHFFFAOYSA-N safranin Chemical compound [Cl-].C=12C=C(N)C(C)=CC2=NC2=CC(C)=C(N)C=C2[N+]=1C1=CC=CC=C1 OARRHUQTFTUEOS-UHFFFAOYSA-N 0.000 description 2
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- 230000001960 triggered effect Effects 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- 108010091326 Cryoglobulins Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 240000001973 Ficus microcarpa Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 208000031886 HIV Infections Diseases 0.000 description 1
- 208000037357 HIV infectious disease Diseases 0.000 description 1
- 206010019372 Heinz bodies Diseases 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920001612 Hydroxyethyl starch Polymers 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 206010027540 Microcytosis Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- 241000227425 Pieris rapae crucivora Species 0.000 description 1
- 208000002151 Pleural effusion Diseases 0.000 description 1
- 229920001100 Polydextrose Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010039207 Rocky Mountain Spotted Fever Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 208000002903 Thalassemia Diseases 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- AXIKDPDWFVPGOD-UHFFFAOYSA-O [7-(dimethylamino)phenothiazin-3-ylidene]-dimethylazanium;2-(2,4,5,7-tetrabromo-3,6-dihydroxyxanthen-10-ium-9-yl)benzoic acid Chemical compound C1=CC(=[N+](C)C)C=C2SC3=CC(N(C)C)=CC=C3N=C21.OC(=O)C1=CC=CC=C1C1=C(C=C(Br)C(O)=C2Br)C2=[O+]C2=C1C=C(Br)C(O)=C2Br AXIKDPDWFVPGOD-UHFFFAOYSA-O 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 210000003969 blast cell Anatomy 0.000 description 1
- 238000004159 blood analysis Methods 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- 201000010902 chronic myelomonocytic leukemia Diseases 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 229940039231 contrast media Drugs 0.000 description 1
- 238000012864 cross contamination Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 229960000633 dextran sulfate Drugs 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000012631 diagnostic technique Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000002296 dynamic light scattering Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000000222 eosinocyte Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000004313 glare Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 210000001907 heinz body Anatomy 0.000 description 1
- 229940027278 hetastarch Drugs 0.000 description 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 238000003709 image segmentation Methods 0.000 description 1
- 201000006747 infectious mononucleosis Diseases 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000006101 laboratory sample Substances 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 230000007762 localization of cell Effects 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 238000010339 medical test Methods 0.000 description 1
- 210000001237 metamyelocyte Anatomy 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 210000000066 myeloid cell Anatomy 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 210000000441 neoplastic stem cell Anatomy 0.000 description 1
- 230000003448 neutrophilic effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000000299 nuclear matrix Anatomy 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 235000013856 polydextrose Nutrition 0.000 description 1
- 239000001259 polydextrose Substances 0.000 description 1
- 229940035035 polydextrose Drugs 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000006903 response to temperature Effects 0.000 description 1
- 206010038796 reticulocytosis Diseases 0.000 description 1
- 239000012898 sample dilution Substances 0.000 description 1
- 238000005464 sample preparation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 208000007056 sickle cell anemia Diseases 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000004895 subcellular structure Anatomy 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000012859 tissue stain Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000003936 working memory Effects 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361799152P | 2013-03-15 | 2013-03-15 | |
| US61/799,152 | 2013-03-15 | ||
| US14/216,811 | 2014-03-17 | ||
| US14/215,834 US9316635B2 (en) | 2013-03-15 | 2014-03-17 | Sheath fluid systems and methods for particle analysis in blood samples |
| US14/216,811 US10705008B2 (en) | 2013-03-15 | 2014-03-17 | Autofocus systems and methods for particle analysis in blood samples |
| US14/217,034 | 2014-03-17 | ||
| US14/215,834 | 2014-03-17 | ||
| US14/217,034 US10429292B2 (en) | 2013-03-15 | 2014-03-17 | Dynamic range extension systems and methods for particle analysis in blood samples |
| US14/216,339 US9279750B2 (en) | 2013-03-15 | 2014-03-17 | Method and composition for staining and sample processing |
| US14/216,339 | 2014-03-17 | ||
| US14/216,533 | 2014-03-17 | ||
| US14/216,533 US9322752B2 (en) | 2013-03-15 | 2014-03-17 | Flowcell systems and methods for particle analysis in blood samples |
| PCT/US2014/030942 WO2014146063A2 (en) | 2013-03-15 | 2014-03-18 | Hematology systems and methods |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016520807A JP2016520807A (ja) | 2016-07-14 |
| JP2016520807A5 true JP2016520807A5 (enExample) | 2019-01-17 |
| JP6483658B2 JP6483658B2 (ja) | 2019-03-13 |
Family
ID=50694017
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016502570A Active JP6523245B2 (ja) | 2013-03-15 | 2014-03-17 | 血液試料における粒子分析のためのシース液システム及び方法 |
| JP2016502595A Active JP6483658B2 (ja) | 2013-03-15 | 2014-03-18 | 血液検査システム及び方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016502570A Active JP6523245B2 (ja) | 2013-03-15 | 2014-03-17 | 血液試料における粒子分析のためのシース液システム及び方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US9316635B2 (enExample) |
| EP (1) | EP2972200B1 (enExample) |
| JP (2) | JP6523245B2 (enExample) |
| KR (2) | KR102053487B1 (enExample) |
| CN (3) | CN113484200B (enExample) |
| BR (2) | BR112015021902B1 (enExample) |
| WO (2) | WO2014145983A1 (enExample) |
Families Citing this family (76)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014145984A1 (en) | 2013-03-15 | 2014-09-18 | Iris International Inc. | Method and composition for staining and sample processing |
| US9857361B2 (en) | 2013-03-15 | 2018-01-02 | Iris International, Inc. | Flowcell, sheath fluid, and autofocus systems and methods for particle analysis in urine samples |
| BR112015021902B1 (pt) * | 2013-03-15 | 2021-06-15 | Iris International, Inc | Líquido para alinhamento de partícula e organela intracelular |
| US20150030215A1 (en) * | 2013-07-26 | 2015-01-29 | Abbott Point Of Care, Inc. | Method and apparatus for producing an image of undiluted whole blood sample having wright stain coloration |
| US10831013B2 (en) | 2013-08-26 | 2020-11-10 | S.D. Sight Diagnostics Ltd. | Digital microscopy systems, methods and computer program products |
| US9832366B2 (en) * | 2014-09-29 | 2017-11-28 | Biosurfit, S.A. | Focusing method |
| US20170299492A1 (en) * | 2014-09-30 | 2017-10-19 | Foss Analytical A/S | Method, device and system for hydrodynamic flow focusing |
| US9429524B2 (en) * | 2014-10-17 | 2016-08-30 | Iris International, Inc. | Systems and methods for imaging fluid samples |
| US20170059590A1 (en) | 2015-08-27 | 2017-03-02 | Ativa Medical Corporation | Fluid holding and dispensing micro-feature |
| US9366606B1 (en) | 2015-08-27 | 2016-06-14 | Ativa Medical Corporation | Fluid processing micro-feature devices and methods |
| US20170059459A1 (en) * | 2015-08-27 | 2017-03-02 | Ativa Medical Corporation | Fluid processing micro-feature devices and methods |
| US11071982B2 (en) | 2015-08-27 | 2021-07-27 | Ativa Medical Corporation | Fluid holding and dispensing micro-feature |
| CN108474727B (zh) * | 2015-12-23 | 2021-10-01 | 西门子保健有限责任公司 | 用于分析在待检测液体中的颗粒的流动室 |
| JP6688089B2 (ja) * | 2016-01-22 | 2020-04-28 | 日本光電工業株式会社 | フローセルおよび粒子分析装置 |
| CA3018536A1 (en) | 2016-03-30 | 2017-10-05 | S.D. Sight Diagnostics Ltd | Distinguishing between blood sample components |
| CN108780031A (zh) * | 2016-03-30 | 2018-11-09 | 西门子保健有限责任公司 | 使用环境粘弹性流体流对准样本流中的非球形生物实体 |
| US10362238B2 (en) * | 2016-04-06 | 2019-07-23 | Biosurfit, S.A. | Method and system for capturing images of a liquid sample |
| JP6942148B2 (ja) | 2016-05-11 | 2021-09-29 | エス．ディー．サイト ダイアグノスティクス リミテッド | 試料に対する光学測定の実施 |
| BE1023760B1 (fr) * | 2016-06-24 | 2017-07-13 | Occhio | Dispositif optique de mesure d'une charge en particules d'un echantillon |
| JP6347353B2 (ja) * | 2016-08-30 | 2018-06-27 | 静岡製機株式会社 | 穀粒の品質測定装置 |
| KR101967820B1 (ko) * | 2017-01-09 | 2019-04-10 | 동아대학교 산학협력단 | 차압 점도계용 미세 흐름 장치 및 이의 설계방법 |
| USD852979S1 (en) * | 2017-01-24 | 2019-07-02 | Life Technologies Corporation | Capillary electrophoresis cartridge |
| EP3602003A1 (en) | 2017-03-31 | 2020-02-05 | Life Technologies Corporation | Apparatuses, systems and methods for imaging flow cytometry |
| EP3630342B1 (en) * | 2017-05-25 | 2022-03-30 | Abbott Laboratories | Methods and systems for sample analysis |
| JP6875944B2 (ja) * | 2017-06-27 | 2021-05-26 | アークレイ株式会社 | フローセル及び測定装置 |
| KR20240059633A (ko) * | 2017-06-28 | 2024-05-07 | 벡톤 디킨슨 앤드 컴퍼니 | 고농도의 분석물을 포함한 분석물을 측정하기 위한 용량 반응 곡선의 신호 부분을 감소시키는 단계를 사용하는 샌드위치-유형 분석법 |
| EP3658125A4 (en) * | 2017-07-28 | 2021-04-28 | National University of Singapore | BIOMOLECULAR COMPOSITES INCLUDING MODIFIED CELL PHANTOMS |
| DE102017008946A1 (de) * | 2017-09-23 | 2019-03-28 | Universität Greifswald | Verfahren zum Verformen von deformierbaren Körpern und Vorrichtungen dazu |
| WO2019090126A1 (en) * | 2017-11-03 | 2019-05-09 | Streck, Inc. | Linearity control materials |
| AU2018369859B2 (en) | 2017-11-14 | 2024-01-25 | S.D. Sight Diagnostics Ltd | Sample carrier for optical measurements |
| CN108226015A (zh) * | 2018-01-04 | 2018-06-29 | 江苏苏净集团有限公司 | 一种新型液体颗粒计数方法及系统 |
| WO2019150997A1 (ja) * | 2018-02-01 | 2019-08-08 | 東レ株式会社 | 液中粒子の評価装置及びその運転方法 |
| CN116609243A (zh) * | 2018-04-28 | 2023-08-18 | 深圳迈瑞生物医疗电子股份有限公司 | 血液分析方法、血液分析系统及存储介质 |
| WO2019221913A1 (en) * | 2018-05-15 | 2019-11-21 | Illumina, Inc. | Flow cell with flexible connection |
| JP7269692B2 (ja) * | 2018-09-26 | 2023-05-09 | シスメックス株式会社 | 検体測定システム及び検体測定方法 |
| CN109374608B (zh) * | 2018-10-18 | 2021-05-28 | 东北大学 | 一种分光光度法检测胺类捕收剂的方法 |
| JP7175158B2 (ja) * | 2018-10-29 | 2022-11-18 | アークレイ株式会社 | 情報処理装置、測定システム、及びプログラム |
| WO2020127563A2 (en) * | 2018-12-21 | 2020-06-25 | Global Life Sciences Solutions Usa Llc | In-process device and method for cell culture monitoring |
| JP7292643B2 (ja) * | 2019-06-04 | 2023-06-19 | 出光興産株式会社 | 観察装置、観察システム、及び観察方法 |
| US11061014B2 (en) | 2019-06-25 | 2021-07-13 | Hemex Health, Inc. | Malaria species detection |
| US12509663B2 (en) | 2019-08-23 | 2025-12-30 | The Penn State Research Foundation | Methods and systems for estimating proportion of filled virus capsids using cryo-EM |
| CN110619318B (zh) * | 2019-09-27 | 2021-03-02 | 腾讯科技（深圳）有限公司 | 基于人工智能的图像处理方法、显微镜、系统和介质 |
| EP4042134B1 (en) | 2019-10-11 | 2024-12-18 | Beckman Coulter, Inc. | Method and composition for staining and sample processing |
| WO2021079305A1 (en) | 2019-10-22 | 2021-04-29 | S.D. Sight Diagnostics Ltd | Accounting for errors in optical measurements |
| US12189112B2 (en) | 2019-12-12 | 2025-01-07 | S.D. Sight Diagnostics Ltd. | Artificial generation of color blood smear image |
| AU2020400400A1 (en) | 2019-12-12 | 2022-05-26 | S.D. Sight Diagnostics Ltd | Detecting platelets in a blood sample |
| AU2020400401A1 (en) | 2019-12-12 | 2022-06-02 | S.D. Sight Diagnostics Ltd | Analyzing an analyte disposed within a medium |
| CN113390867A (zh) * | 2020-03-12 | 2021-09-14 | 平湖莱顿光学仪器制造有限公司 | 一种黏滞性相关的智能二维视频播放方法及其视频装置 |
| CN111721950A (zh) * | 2020-05-29 | 2020-09-29 | 迪瑞医疗科技股份有限公司 | 一种稳定的有形成分分析聚焦液及其制备方法 |
| CN111721705A (zh) * | 2020-06-12 | 2020-09-29 | 迪瑞医疗科技股份有限公司 | 一种妇科分泌物分析仪器用层流液及其制备方法 |
| CN111979112A (zh) * | 2020-08-25 | 2020-11-24 | 郑州金域临床检验中心有限公司 | 一种细胞计数装置及其使用方法 |
| JP7417503B2 (ja) | 2020-09-25 | 2024-01-18 | 芝浦機械株式会社 | 加工機、計測装置及び被加工物の製造方法 |
| EP3995807A1 (en) * | 2020-11-06 | 2022-05-11 | Technische Universität München | Analysis of tissue samples using quantitative phase-contrast microscopy |
| WO2022107132A1 (en) * | 2020-11-17 | 2022-05-27 | Scopio Labs Ltd. | Detecting scan area within hematology slides in digital microscopy |
| EP4067866B1 (en) * | 2021-04-01 | 2025-11-05 | Leica Microsystems CMS GmbH | Imaging system and method for imaging biological samples |
| EP4457496A1 (en) | 2021-12-29 | 2024-11-06 | Beckman Coulter, Inc. | Biological sample driving system and method |
| CN118648020A (zh) | 2022-02-02 | 2024-09-13 | 贝克曼库尔特有限公司 | 测量血细胞图像的图像质量 |
| US20250182504A1 (en) * | 2022-02-24 | 2025-06-05 | Scopio Labs Ltd. | Morphology based verifiable screening |
| US20250208026A1 (en) * | 2022-03-11 | 2025-06-26 | Beckman Coulter, Inc. | Controls and their use in analyzers |
| KR102869509B1 (ko) * | 2022-06-02 | 2025-10-14 | (주)유아이엠디 | 혈액 샘플의 이미지 분석 정보 제공 방법 |
| CN114878846B (zh) * | 2022-07-08 | 2022-11-22 | 深圳市帝迈生物技术有限公司 | 一种血液分析仪及其清洗方法 |
| US20240027310A1 (en) | 2022-07-22 | 2024-01-25 | Beckman Coulter, Inc. | Biological sample staining module and biological analysis systems and methods |
| EP4630784A1 (en) | 2022-12-05 | 2025-10-15 | Beckman Coulter, Inc. | Multi-channel hematology flow system |
| GB202218615D0 (en) * | 2022-12-12 | 2023-01-25 | S D Sight Diagnostics Ltd | System and method for analyzing bodily samples |
| CN120380512A (zh) | 2022-12-22 | 2025-07-25 | 贝克曼库尔特有限公司 | 用于血细胞图像的多级图像分类器 |
| CN116286629A (zh) * | 2023-03-07 | 2023-06-23 | 上海兰桥生物科技有限公司 | 红细胞处理剂、抗凝剂及细胞处理方法 |
| WO2025014621A1 (en) * | 2023-07-12 | 2025-01-16 | Beckman Coulter, Inc. | Biological sample analysis techniques |
| WO2025016519A1 (en) * | 2023-07-20 | 2025-01-23 | ParticleTech ApS | A method for transverse photographic analysis of dry particulate substances while suspended in a fluid |
| CN116807527A (zh) * | 2023-07-21 | 2023-09-29 | 淮安市第二人民医院 | 一种安全型肿瘤取样装置 |
| WO2025059453A1 (en) | 2023-09-13 | 2025-03-20 | Beckman Coulter, Inc. | Using trained machine learning models to determine alignment characteristics |
| WO2025059446A1 (en) | 2023-09-13 | 2025-03-20 | Beckman Coulter, Inc. | Imaging techniques to determine blood cell characteristics |
| WO2025144690A1 (en) * | 2023-12-27 | 2025-07-03 | Beckman Coulter, Inc. | Systems and methods of processing samples comprising immature granulocytes |
| WO2025245513A1 (en) | 2024-05-24 | 2025-11-27 | Beckman Coulter, Inc. | Assessing and enhancing biological analyzer functionality through particle staining |
| WO2025245510A1 (en) | 2024-05-24 | 2025-11-27 | Beckman Coulter, Inc. | Patient and control sample based analyzer evaluation |
| CN120558819B (zh) * | 2025-07-31 | 2025-09-30 | 山西白求恩医院(山西医学科学院、华中科技大学同济医学院附属同济医院山西医院、山西医科大学第三医院、山西医科大学第三临床医学院) | 一种流式细胞仪的分选控制系统及分选方法 |
| CN120971301A (zh) * | 2025-10-17 | 2025-11-18 | 中国科学院空天信息创新研究院 | 一体化三维鞘流通道集成学习血细胞分析仪及方法 |
Family Cites Families (80)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3888782A (en) * | 1972-05-08 | 1975-06-10 | Allergan Pharma | Soft contact lens preserving solution |
| US3822095A (en) * | 1972-08-14 | 1974-07-02 | Block Engineering | System for differentiating particles |
| GB1471976A (en) | 1974-09-20 | 1977-04-27 | Coulter Electronics | Particle sensing apparatus including a device for orienting generally flat particles |
| DE2543310C2 (de) | 1975-09-27 | 1982-04-29 | Gesellschaft für Strahlen- und Umweltforschung mbH, 8000 München | Einrichtung zum Zählen und Klassifizieren von in einer Flüssigkeit suspendierten Teilchen |
| US4338024A (en) | 1980-05-02 | 1982-07-06 | International Remote Imaging Systems, Inc. | Flow analyzer and system for analysis of fluids with particles |
| FR2484077B1 (fr) | 1980-06-06 | 1984-07-06 | Inst Nat Sante Rech Med | Procede et dispositif de mesure de la deformabilite de cellules vivantes, notamment des globules rouges du sang |
| JPS5774372A (en) * | 1980-10-27 | 1982-05-10 | Seiko Epson Corp | Fluid ink for printer |
| DE3315195A1 (de) | 1982-04-29 | 1983-11-03 | International Remote Imaging Systems Inc., 91311 Chatsworth, Calif. | Verfahren zum ausrichten von teilchen in einer fluidprobe |
| AU563260B2 (en) * | 1984-11-29 | 1987-07-02 | International Remote Imaging Systems Inc. | Method of operating a microscopic instrument |
| US4732479A (en) | 1985-10-18 | 1988-03-22 | Canon Kabushiki Kaisha | Particle analyzing apparatus |
| US4983038A (en) | 1987-04-08 | 1991-01-08 | Hitachi, Ltd. | Sheath flow type flow-cell device |
| DE3902079A1 (de) * | 1988-04-15 | 1989-10-26 | Bayer Ag | I.m. injektionsformen von gyrase-inhibitoren |
| US5123055A (en) | 1989-08-10 | 1992-06-16 | International Remote Imaging Systems, Inc. | Method and an apparatus for differentiating a sample of biological cells |
| JP2939647B2 (ja) | 1990-07-24 | 1999-08-25 | シスメックス株式会社 | フローイメージングサイトメータにおける自動焦点調整方法 |
| JP2874746B2 (ja) | 1990-11-22 | 1999-03-24 | シスメックス株式会社 | フローイメージングサイトメータにおけるフローセル機構 |
| US5412466A (en) * | 1991-07-26 | 1995-05-02 | Toa Medical Electronics Co., Ltd. | Apparatus for forming flattened sample flow for analyzing particles |
| JP3111706B2 (ja) * | 1992-02-18 | 2000-11-27 | 株式会社日立製作所 | 粒子分析装置及び粒子分析方法 |
| DE69327182T2 (de) | 1992-02-18 | 2000-06-15 | Hitachi, Ltd. | Gerät und Verfahren zur Untersuchung von Teilchen in einem Fluid |
| US5308526A (en) * | 1992-07-07 | 1994-05-03 | The Procter & Gamble Company | Liquid personal cleanser with moisturizer |
| JP3215175B2 (ja) | 1992-08-10 | 2001-10-02 | シスメックス株式会社 | 粒子分析装置 |
| JP3052665B2 (ja) * | 1993-01-26 | 2000-06-19 | 株式会社日立製作所 | フローセル装置 |
| US5585246A (en) | 1993-02-17 | 1996-12-17 | Biometric Imaging, Inc. | Method for preparing a sample in a scan capillary for immunofluorescent interrogation |
| JP3039594B2 (ja) | 1993-10-08 | 2000-05-08 | 株式会社日立製作所 | 染色試薬およびその使用方法 |
| JP3290786B2 (ja) | 1993-11-26 | 2002-06-10 | シスメックス株式会社 | 粒子分析装置 |
| US5812419A (en) * | 1994-08-01 | 1998-09-22 | Abbott Laboratories | Fully automated analysis method with optical system for blood cell analyzer |
| WO1996020456A1 (en) | 1994-12-23 | 1996-07-04 | International Remote Imaging Systems, Inc. | Method and apparatus of analyzing particles in a fluid sample and displaying same |
| JPH0989753A (ja) * | 1995-09-25 | 1997-04-04 | Hitachi Ltd | 粒子分析装置 |
| WO1997043620A1 (en) | 1996-05-15 | 1997-11-20 | International Remote Imaging Systems, Inc. | Selectively emphasizing particles of interest from a fluid sample for analysis |
| US6184978B1 (en) | 1996-05-15 | 2001-02-06 | International Remote Imaging Systems, Inc. | Method and apparatus for verifying uniform flow of a fluid sample through a flow cell and distribution on a slide |
| KR100200734B1 (ko) | 1996-10-10 | 1999-06-15 | 윤종용 | 에어리얼 이미지 측정 장치 및 방법 |
| US5985216A (en) | 1997-07-24 | 1999-11-16 | The United States Of America, As Represented By The Secretary Of Agriculture | Flow cytometry nozzle for high efficiency cell sorting |
| US5935857A (en) | 1997-08-01 | 1999-08-10 | Coulter International Corp. | Blood diluent |
| AU754644B2 (en) | 1998-08-21 | 2002-11-21 | Union Biometrica, Inc. | Instrument for selecting and depositing multicellular organisms and other large objects |
| US20030059440A1 (en) * | 1998-09-01 | 2003-03-27 | Tim Clarot | Composition and method for moisturizing nasal tissue |
| US6130745A (en) | 1999-01-07 | 2000-10-10 | Biometric Imaging, Inc. | Optical autofocus for use with microtiter plates |
| JP2000214070A (ja) | 1999-01-21 | 2000-08-04 | Sysmex Corp | シ―スフロ―セルとそれを用いた血液分析装置 |
| US6632676B1 (en) | 1999-09-24 | 2003-10-14 | Clinical Diagnostic Solutions | Multi-purpose reagent system and method for enumeration of red blood cells, white blood cells and thrombocytes and differential determination of white blood cells |
| CA2396015A1 (en) | 1999-12-29 | 2001-07-05 | Union Biometrica, Inc. | High viscosity sheath reagent for flow cytometry |
| US6974938B1 (en) | 2000-03-08 | 2005-12-13 | Tibotec Bvba | Microscope having a stable autofocusing apparatus |
| CA2349995A1 (en) | 2000-06-14 | 2001-12-14 | Lianne Ing | Viewing particles in a relatively translucent medium |
| US20040070757A1 (en) | 2000-12-29 | 2004-04-15 | Moore Richard Channing | High viscosity sheath reagent for flow cytometry |
| FR2821428B1 (fr) | 2001-02-23 | 2004-08-06 | Abx Sa | Reactif et procede pour l'identification et le comptage de cellules biologiques |
| JP4838446B2 (ja) | 2001-06-20 | 2011-12-14 | オリンパス株式会社 | 顕微鏡装置 |
| KR100473362B1 (ko) * | 2001-10-17 | 2005-03-08 | 주식회사 디지탈바이오테크놀러지 | 미세 입자 분석 장치 및 방법 |
| AU2003261795A1 (en) | 2002-09-05 | 2004-03-29 | Fuji Electric Systems Co., Ltd. | Method for detecting microbe or cell |
| EP1565795B1 (en) | 2002-11-18 | 2008-11-12 | International Remote Imaging Systems, Inc. | A multi-level controller system |
| US6825926B2 (en) | 2002-11-19 | 2004-11-30 | International Remote Imaging Systems, Inc. | Flow cell for urinalysis diagnostic system and method of making same |
| US6900058B2 (en) | 2003-03-11 | 2005-05-31 | Bionostics, Inc. | Control solution for photometric analysis |
| GB0321918D0 (en) * | 2003-09-19 | 2003-10-22 | Aoti Operating Co Inc | Focusing system and method |
| JP4057539B2 (ja) * | 2004-01-09 | 2008-03-05 | 浜松ホトニクス株式会社 | シースフローセルキュベット及びその製造方法 |
| US9176121B2 (en) | 2004-02-13 | 2015-11-03 | Roche Diagnostics Hematology, Inc. | Identification of blood elements using inverted microscopy |
| US7394943B2 (en) | 2004-06-30 | 2008-07-01 | Applera Corporation | Methods, software, and apparatus for focusing an optical system using computer image analysis |
| JP2006039315A (ja) | 2004-07-28 | 2006-02-09 | Hamamatsu Photonics Kk | 自動焦点装置及びそれを用いた顕微鏡装置 |
| US7822276B2 (en) | 2005-02-17 | 2010-10-26 | Iris International, Inc. | Method and apparatus for analyzing body fluids |
| FR2883972B1 (fr) * | 2005-03-31 | 2007-11-16 | C2 Diagnostics Sa | Procede pour l'analyse d'un echantillon de sang et appareil et reactif pour sa mise en oeuvre |
| JP2007024844A (ja) | 2005-07-21 | 2007-02-01 | Sysmex Corp | 血液分析方法及び血液分析装置 |
| JP4896534B2 (ja) | 2006-01-31 | 2012-03-14 | シスメックス株式会社 | 粒子分析装置用シース液 |
| JPWO2007145091A1 (ja) | 2006-06-15 | 2009-10-29 | 株式会社ニコン | 細胞培養装置 |
| DE102006027836B4 (de) | 2006-06-16 | 2020-02-20 | Carl Zeiss Microscopy Gmbh | Mikroskop mit Autofokuseinrichtung |
| SE530750C2 (sv) * | 2006-07-19 | 2008-09-02 | Hemocue Ab | En mätapparat, en metod och ett datorprogram |
| CN1945326A (zh) | 2006-10-13 | 2007-04-11 | 江西特康科技有限公司 | 基于视觉形态的五分类全血细胞分析方法 |
| US9110010B2 (en) * | 2007-05-11 | 2015-08-18 | The United States Of America, As Represented By The Secretary Of The Navy | Electrical detection using confined fluids |
| CN101772697B (zh) | 2007-06-07 | 2013-08-21 | 技术研究及发展基金有限公司 | 用于聚集颗粒的系统和方法 |
| US9602777B2 (en) | 2008-04-25 | 2017-03-21 | Roche Diagnostics Hematology, Inc. | Systems and methods for analyzing body fluids |
| JP2012515931A (ja) | 2008-04-25 | 2012-07-12 | ウィンケルマン、ジェイムズ | 全血球数及び白血球百分率を決定するシステム及び方法 |
| US8343978B2 (en) * | 2008-08-04 | 2013-01-01 | Adds Pharmaceuticals Llc | Fast onset orodispersable tablets |
| CN104155210B (zh) * | 2008-10-02 | 2017-08-22 | 彼克斯赛尔医疗科技有限公司 | 基于粘弹性聚焦的光学成像 |
| KR101133288B1 (ko) | 2008-12-24 | 2012-04-05 | 한국과학기술원 | 미세입자 분리 장치 및 방법 |
| JP5337912B2 (ja) | 2009-06-10 | 2013-11-06 | シンベニオ・バイオシステムズ・インコーポレーテッド | シース流装置及び方法 |
| WO2011026141A2 (en) | 2009-08-31 | 2011-03-03 | Life Technologies Corporation | Fast-indexing filter wheel and method of use |
| US8445284B2 (en) | 2011-06-17 | 2013-05-21 | Constitution Medical, Inc. | Fixative and staining solutions |
| KR101849974B1 (ko) | 2011-09-16 | 2018-04-19 | 삼성전자주식회사 | 개구수 제어 유닛, 이를 채용한 가변형 광 프로브 및 깊이 스캐닝 방법 |
| US9810704B2 (en) | 2013-02-18 | 2017-11-07 | Theranos, Inc. | Systems and methods for multi-analysis |
| KR101244285B1 (ko) | 2011-12-21 | 2013-03-18 | 충남대학교산학협력단 | 액적 발생용 마이크로 유체칩, 액적 반응용 마이크로 유체칩 및 다중 액적반응 분석장치 |
| CN102998437A (zh) | 2012-11-26 | 2013-03-27 | 江苏美诚生物科技有限公司 | 尿沉渣分析用鞘液及其制备方法 |
| KR101389554B1 (ko) | 2012-11-26 | 2014-04-29 | 경희대학교 산학협력단 | 유세포 계수기의 유체 채널 및 유세포 계수법 |
| BR112015023425B1 (pt) | 2013-03-15 | 2021-01-12 | Iris International, Inc. | método e composição para coloração e processamento de uma amostra de urina |
| BR112015021902B1 (pt) * | 2013-03-15 | 2021-06-15 | Iris International, Inc | Líquido para alinhamento de partícula e organela intracelular |
| US9857361B2 (en) * | 2013-03-15 | 2018-01-02 | Iris International, Inc. | Flowcell, sheath fluid, and autofocus systems and methods for particle analysis in urine samples |
| WO2014145984A1 (en) | 2013-03-15 | 2014-09-18 | Iris International Inc. | Method and composition for staining and sample processing |
-
2014
- 2014-03-17 BR BR112015021902-0A patent/BR112015021902B1/pt not_active IP Right Cessation
- 2014-03-17 WO PCT/US2014/030850 patent/WO2014145983A1/en not_active Ceased
- 2014-03-17 US US14/215,834 patent/US9316635B2/en active Active
- 2014-03-17 JP JP2016502570A patent/JP6523245B2/ja active Active
- 2014-03-17 KR KR1020157024436A patent/KR102053487B1/ko active Active
- 2014-03-18 KR KR1020157024441A patent/KR102044593B1/ko active Active
- 2014-03-18 CN CN202110774856.4A patent/CN113484200B/zh active Active
- 2014-03-18 BR BR112015021577-7A patent/BR112015021577B1/pt not_active IP Right Cessation
- 2014-03-18 JP JP2016502595A patent/JP6483658B2/ja active Active
- 2014-03-18 CN CN201480015388.0A patent/CN105074420B/zh active Active
- 2014-03-18 EP EP14725288.6A patent/EP2972200B1/en active Active
- 2014-03-18 CN CN202410374633.2A patent/CN118362466A/zh active Pending
- 2014-03-18 WO PCT/US2014/030942 patent/WO2014146063A2/en not_active Ceased
-
2016
- 2016-03-08 US US15/064,129 patent/US9470618B2/en active Active
- 2016-09-12 US US15/263,001 patent/US10451612B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6483658B2 (ja) | 血液検査システム及び方法 | |
| US10060846B2 (en) | Hematology systems and methods | |
| JP2016520807A5 (enExample) | ||
| EP2972215B1 (en) | Methods for particle analysis in body fluid | |
| US12529641B2 (en) | Autofocus systems and methods for particle analysis in blood samples | |
| US12529642B2 (en) | Autofocus systems and methods for particle analysis in blood samples | |
| HK40009534B (en) | Method for imaging particles | |
| HK40002305B (zh) | 用於體液樣品中的粒子分析的自聚焦系統和方法 | |
| HK40002305A (en) | Autofocus systems and methods for particle analysis in body fluid samples |